about
Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and EltrombopagRapunzel syndrome: a rare cause of hypoproteinaemia and review of literature.Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review.Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation.Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events.Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation.Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia.Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature.Quetiapine Associated Thrombotic Thrombocytopenic Purpura: A Case Report and Literature Review.Blinatumomab-induced donor T-cell activation for post-stem cell transplant-relapsed acute CD19-positive biphenotypic leukemia.Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies.Successful recovery and allogeneic stem cell transplant following chemotherapy-induced severe cardiomyopathy: literature review of management and prognostic factors.Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review.Waldenström Macroglobulinemia: Review of Pathogenesis and Management.A Review of Autologous Stem Cell Transplantation in Lymphoma.Cardiovascular Oncologic Emergencies.Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.Intractable cerebral Nocardia mexicana in a GvHD patient successfully treated with linezolid.Lymphomatous orbital infiltration and vision loss in diffuse large B-cell lymphoma.Patterns of pancytopenia patients in a general medical ward and a proposed diagnostic approach.Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.NK/T-cell non-Hodgkin's lymphoma with secondary haemophagocytic lymphohistiocytosis treated with matched unrelated donor allogeneic stem cell transplantSpontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.Nephrotic syndrome secondary to proliferative glomerulonephritis with monoclonal immunoglobulin deposits of lambda light chain.Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy.Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Patients: A Single-center Experience.Coccidioidomycosis, immunoglobulin deficiency: safety challenges with CAR T cells therapy for relapsed lymphoma.Posterior reversible encephalopathy syndrome in malignant hypertension secondary to focal segmental glomerulosclerosis.Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis.Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas.Bone lymphoma with multiple negative bone biopsies.Case of relentless chronic phase of chronic myeloid leukaemia.Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth review.
P50
Q33424451-FBBE9ADE-E335-4063-B46C-10A8CFFF6D87Q33424486-EFC08ABA-B7FB-47CE-92B0-8ACD93944556Q34678928-8BAFFCD5-0F9F-4295-8D9B-4FCE6D303702Q35930014-016270B5-866C-4BC7-9948-DE2BCB9AA1E2Q36072365-A12A6FD0-389B-4A1F-8F4C-6406F8AEAF31Q36232484-222FE58B-75A2-44C0-B949-6EA1E21824D3Q37618366-1039DB98-AA7A-4E8E-B9BA-2C7B2E639C6CQ37711769-0A6F5EA0-4F00-4B6A-A8CA-60A9E18F46A3Q37736162-2DAE4448-D804-4812-BEF2-4ECB9916AFA2Q38644775-93E78EF1-681B-4C80-B2FB-A3A7C49F07ABQ38647546-023593D4-50FC-498D-BB99-B590AA5C582EQ38703559-5AC6301A-2A82-42BE-8D75-93516F7D167FQ38828147-04F05A49-9A98-45F2-9E8E-F906241C00F4Q38875875-EC446D64-BF50-484C-A985-EB4EC707E3FAQ38887291-ACB0BDF3-D529-4BA3-8C62-9109824ACB30Q38996073-76A2713D-8316-4D76-8786-4952BDC3E89CQ39010412-7374E4B4-2444-426A-964E-8E64B90E73F6Q39106490-E0D09A97-9837-4B0D-BE02-11E5428DFB35Q39214071-BCE04C17-806C-47FF-A257-ECF0C665B1ECQ39288544-2C63BBF4-6562-4205-8B62-0FF68ABB24BCQ39401045-4F54E279-471D-40ED-B07C-123951047724Q40061748-8BE0D7D8-1052-4568-AA6C-FDDB8302008CQ40104083-A0BAE78C-456A-40E1-B32A-4F9117963518Q40114389-0BC4E983-9744-452A-BD28-C7FF709C06C0Q40534449-9C349520-F62C-426A-82E9-22D14F02037BQ40597967-AE3001B8-384D-468B-8F87-5F52437987B1Q41781367-FCC46091-E346-42EB-848B-F48A859E0923Q41968809-8815BCC2-32B9-476A-905E-8A991EBB4F15Q42201261-B88CE167-0D1C-4538-9836-44B66E5B12B2Q42292376-7FE68E81-1F70-400D-A9B7-22649DCE7C1BQ46014846-F35D06D0-937F-46DE-A1CC-70AADE75B69CQ46039254-DD808113-2BE0-42E3-A583-4E9993C87935Q47793288-FEFD78DF-64CE-4B9E-BB50-480F73C276A6Q48565122-0257B481-B881-44E4-B23A-BC5E1FA9F471Q50027149-0BB01E50-2B6F-4139-B9C1-5B7157B757CAQ50065599-348579AE-DD66-49B0-B47A-4DBFCC94D4FCQ50247776-D7112BC1-6EF0-4ED2-B95A-28347A0F4BFFQ51686970-C7CA9E6A-EEE6-4021-A216-AE362DC847BEQ52318771-26C1126F-0E5D-4735-AF9E-FAB8F9C6640FQ52715646-16D92369-46D0-4191-BBAE-7B42E0BEC8DB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Faiz Anwer
@ast
Faiz Anwer
@en
Faiz Anwer
@es
Faiz Anwer
@nl
Faiz Anwer
@sl
type
label
Faiz Anwer
@ast
Faiz Anwer
@en
Faiz Anwer
@es
Faiz Anwer
@nl
Faiz Anwer
@sl
prefLabel
Faiz Anwer
@ast
Faiz Anwer
@en
Faiz Anwer
@es
Faiz Anwer
@nl
Faiz Anwer
@sl
P1053
B-6837-2011
P106
P108
P1153
56180064500
P21
P31
P3829
P496
0000-0001-6914-7439